Biotech Business - August 11, 2021
Almi Invest invests in Strike Pharma
Almi Invest will invest just over 2 million SEK in the newly founded Uppsala-based company Strike Pharma. As previously reported by NLS, an immunotherapeutic cancer vaccine delivery-platform has been developed at the SciLifeLab Drug Discovery and Development platform (DDD). The researchers will continue to develop the method within the framework of the newly started company, […]
Financing - January 4, 2017
Antaros Medical and Almi Invest adds 3 MSEK to Emeriti Pharma
Emeriti Pharma, which is developing a new treatment for skin diseases, takes up two million in venture capital from Antaros Medical. The existing owner, Almi Invest, is also participating in the funding, which has a total value of three million SEK. Emeriti Pharma also announces that the company is currently conducting a Phase 1 study […]
Financing - November 14, 2016
Novo Seeds and Almi Invest co-invest in rare disease start-up
Novo Seeds and Almi Invest are to jointly invest up to 6,3 million SEK in rare disease start-up Merozyne Therapeutics dependent on pre-agreed milestones. Merozyne Therapeutics aims to develop a small molecule inhibitor for the treatment of congenital muscular dystrophy (MDC1A). Currently there is no cure for MDC1A, which is caused by an absence of […]
